Gallbladder cancer
Showing 1 - 25 of >10,000
Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy
Enrolling by invitation
- Gallbladder Cancer
- Minimally invasive surgery
-
Barcelona, SpainHospital del Mar
Sep 25, 2023
Unresectable Gallbladder Cancer Trial in Guangzhou (Carrilizumab plus GEMOX)
Not yet recruiting
- Unresectable Gallbladder Cancer
- Carrilizumab plus GEMOX
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 16, 2023
Deep Learning Radiogenomics For Individualized Therapy in
Recruiting
- Gallbladder Cancer
- CT scan
-
Chandigarh, Punjab, IndiaPost Graduate Institute of Medical Education and Research
Feb 6, 2023
Gallbladder Cancer, Initially Unresectable, the First Line Treatment Trial in Shanghai (Combination of Gemcitabine,
Recruiting
- Gallbladder Cancer
- +2 more
- Combination of Gemcitabine, Nab-paclitaxel, Sintilimab and Bevacizumab
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 24, 2023
Stage II Gallbladder Cancer AJCC v8, Stage IIA Gallbladder Cancer AJCC v8, Stage IIB Gallbladder Cancer AJCC v8 Trial in Atlanta
Recruiting
- Stage II Gallbladder Cancer AJCC v8
- +5 more
- Cisplatin
- +3 more
-
Atlanta, GeorgiaEmory University, Winship Cancer Institute
Jan 3, 2023
Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester
Active, not recruiting
- Cholangiocarcinoma
- +6 more
- Laboratory Biomarker Analysis
- Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
-
Scottsdale, Arizona
- +1 more
Jan 4, 2023
Gallbladder Cancer Trial in Varanasi (Everolimus 10 mg, Standard of care)
Recruiting
- Gallbladder Cancer
- Everolimus 10 mg
- Standard of care
-
Varanasi, UP, IndiaBanaras Hindu University
Apr 18, 2023
Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic
Active, not recruiting
- Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
- +27 more
- Durvalumab
- Guadecitabine
-
Los Angeles, California
- +2 more
Aug 5, 2022
Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,
Active, not recruiting
- Advanced Bile Duct Carcinoma
- +17 more
- Irinotecan
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jan 5, 2023
Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer Trial in Tianjin
Recruiting
- Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Nov 16, 2022
Gallbladder Cancer Unresectable Trial in Lucknow (chemoradiation)
Recruiting
- Gallbladder Cancer Unresectable
- chemoradiation
-
Lucknow, Uttar Pradesh, IndiaSanjay Gandhi Postgraduate Institute of Medical Sciences
Aug 6, 2022
Gallbladder Cancer Trial in Varanasi (Next generation sequencing)
Recruiting
- Gallbladder Cancer
- Next generation sequencing
-
Varanasi, UP, IndiaBanaras Hindu University
Jun 2, 2022
Cholangiocarcinoma, Liver and Intrahepatic Bile Duct Carcinoma, Stage III Gallbladder Cancer AJCC v7 Trial in Houston
Completed
- Cholangiocarcinoma
- +11 more
- Laboratory Biomarker Analysis
- Ramucirumab
-
Houston, TexasM D Anderson Cancer Center
Jul 7, 2022
Poorly Differentiated Adenocarcinoma With Signet Ring Cells of
Completed
- Gallbladder Cancer
- laparoscopic whole-layer cholecystectomy
-
Ōita, Oita, Japanoita Red Cross hospital
Sep 24, 2022
Patients With Cholangiocarcinoma and Gallbladder Cancer
Recruiting
- Biliary Tract Cancer
- +2 more
-
Herlev, Copenhagen, DenmarkHerlev & Gentofte Hospital
Dec 21, 2021
Breast Cancer, Prostate Cancer, Melanoma (Skin) Trial in Baltimore (Written Weight Loss Material, Weight Loss App, Behavioral
Active, not recruiting
- Breast Cancer
- +7 more
- Written Weight Loss Material
- +2 more
-
Baltimore, MarylandJohns Hopkins ProHealth
Jan 19, 2023
Biliary Tract Tumors, Gallbladder Cancer, Cholangiocarcinoma Trial in Seoul (Durvalumab + Gem/Cis, Gem/Cis)
Active, not recruiting
- Biliary Tract Neoplasms
- +2 more
- Durvalumab + Gem/Cis
- Gem/Cis
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 30, 2023
Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)
Not yet recruiting
- Biliary Tract Diseases
- +5 more
- no interventions
- (no location specified)
Jun 1, 2023
Cholelithiasis, Cholecystitis, Gallbladder Cancer Trial (single transversus abdominis laparoscopy-guided plane block, local
Not yet recruiting
- Cholelithiasis
- +2 more
- single transversus abdominis laparoscopy-guided plane block
- local trocar site ropivacaine infiltration
- (no location specified)
Nov 13, 2023
Multi-Platform Profiling of Resected Biliary Tract Cancer
Recruiting
- Biliary Tract Cancer
- +7 more
- Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
-
Chicago, Illinois
- +1 more
Jan 23, 2023
Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Seongnam-si (nab-paclitaxel plus gemcitabine-cisplatin)
Recruiting
- Biliary Tract Cancer
- +2 more
- nab-paclitaxel plus gemcitabine-cisplatin
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofCHA Bundang Medical Center
Oct 27, 2022
Gallbladder Cancer Trial in London (Shortened hydration time and dispensary of Akynzeo, Standard of care)
Recruiting
- Gallbladder Cancer
- Shortened hydration time and dispensary of Akynzeo
- Standard of care
-
London, United KingdomImperial College Healthcare NHS Trust
Jul 14, 2022